4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-24-000050
Options or other derivatives
- EVP, Chief Scientific Officer acquired 37,400 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
BENNETT C FRANK · EVP, Chief Scientific Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-01-15 | Grant or award : show line 1 in the form Performance Restricted Stock Units | +17,000 | $0.00 | 17,000 | 41,482 | D |
| 2024-01-15 | Grant or award : show line 2 in the form Restricted Stock Unit | +20,400 | $0.00 | 20,400 | 41,814 | D |
Loading xslF345X05/edgardoc.xml…